Table 3.
Multivariate Analysis of Factors Associated With Mortality
| Variable | OR (95% CI) | P Value |
|---|---|---|
| Treatment group | . . . | . . . |
| Ivermectin | 0.27 (0.09-0.80) | .03 |
| Control subject | Reference | . . . |
| Age | 1.05 (1.02-1.09) | .003 |
| Sex | . . . | . . . |
| Female | 0.42 (0.24-1.82) | .42 |
| Male | Reference | . . . |
| Smoking status | . . . | . . . |
| Current or former smoker | 3.49 (0.71-17.32) | .13 |
| Nonsmoker | Reference | . . . |
| Race | . . . | .18 |
| Black | 0.64 (0.21-1.94) | .43 |
| Hispanic | 0.14 (0.02-1.22) | .08 |
| Other | 0.62 (0.05-7.92) | .71 |
| White | Reference | . . . |
| Comorbidities | . . . | . . . |
| Diabetes | 1.17 (0.39-3.55) | .78 |
| Cardiac | 1.51 (0.43-5.22) | .52 |
| Pulmonary | 0.15 (0.20-1.84) | .15 |
| Hypertension | 0.72 (0.17-3.08) | .66 |
| No comorbidities | Reference | . . . |
| BMI | 0.97 (0.89-1.07) | .58 |
| Severe presentation | 11.41 (3.42-38.09) | < .001 |
| Intubated at study entry | 2.96 (0.73-12.06) | .13 |
| MAP ≤ 70 mm Hg | 1.82 (0.17-19.1) | .62 |
| Corticosteroid treatment | 1.71 (0.57-5.16) | .34 |
| Peripheral WBC count | 1.08 (0.96-1.23) | .22 |
| Lymphocyte count | 3.65 (1.25-10.60) | .02 |
MAP = mean arterial pressure.